80 - Yet More Consults! Microbes and "noninfectious" diseases

Speaker(s)

• 

  Tal Danino, PhD

  Associate Professor
  Columbia University

  Disclosure: GenCirq : Board Member (Status: Ongoing), Shareholder (Status: Ongoing)
• 

  Jonathan Lynch, PhD

  Assistant project scientist
  University of California, Los Angeles
  Los Angeles, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Bernd Schnabl, MD

  Professor of Medicine
  University of California San Diego
  San Diego, California

  Disclosure: Axial Biotherapeutics : Grant/Research Support (Status: Ongoing); BiomX : Grant/Research Support (Status: Ongoing); CymaBay Therapeutics : Grant/Research Support (Status: Terminated --- 06/30/2020); Ferring Pharmaceuticals and Research Institute : Consultant (Status: Ongoing); HOST Therabiomics : Consultant (Status: Terminated --- May 12, 2017); Intercept Pharmaceuticals : Consultant (Status: Terminated --- October 12, 2018); Mabwell Therapeutics : Consultant (Status: Ongoing); Patara Pharmaceuticals : Consultant (Status: Terminated --- May 20, 2019); Synlogic Operating Company : Grant/Research Support (Status: Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-470-H04-P

Learning Objectives:

• explain the potential for microbe based cancer therapy
• recognize the contribution of the gut microbiome to liver disease
• identify the contribution of gut microbes to serotonin synthesis

Presentations:

• 11:30am – 12:45pm EDT

  Bidirectional Relationships Between Serotonin and the Gut Microbiota
  Jonathan Lynch, PhD – University of California, Los Angeles
• 11:30am – 12:45pm EDT

  Gut Pathobionts and Liver Disease
  Bernd Schnabl, MD – University of California San Diego
• 11:30am – 12:45pm EDT

  Programmable Bacteria as Cancer Therapies
  Tal Danino, PhD – Columbia University